Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 832-253-5 | CAS number: 12165-18-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
There is no experimental data available for the substance dipraseodymium dizirconium heptaoxide for the endpoints skin irritation and eye irritation. However, based on a weight of evidence approach including experimental data available for its constituents praseodymium(III,IV) oxide and zirconium dioxide, it can be concluded that the substance is not irritant to skin or eyes and does not require to be classified as a skin or eye irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro skin irritation study does not need to be conducted because adequate data from an in vivo skin irritation study are available
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation
1. Information on praseodymium(III,IV) oxide
In the guideline study performed by Shapiro (1991; Klimisch 2), 0.5 g of the test material was applied to both an intact and abraded site on each of six New Zealand White rabbits. The sites were occluded for 24 hours, after which the patches were removed and the test sites wiped to prevent further exposure. Evaluation occurred 24 and 72 hours after exposure. With the exception of one rabbit, which exhibited very slight erythema without oedema at both the intact and abraded site at 24 hours (reversible within 72 h), all sites were clear of irritation during the test period (PDII = 0.09). This study was considered reliable with restrictions because no observations were made at 48 hours after exposure. Based on the results of this study, praseodymium(III,IV) oxide is considered not be a dermal irritant and does not require classification.
2. Information on zirconium dioxide
In a guideline study performed by The British Industrial Biological Research Association (1986; Klimisch 2), zirconium dioxide was found not to be irritating to the skin of New Zealand White rabbits. The overall irritation score was calculated to be zero and hence, it can be concluded that zirconium dioxide does not need to be classified for skin irritation.
3. Conclusion on the substance dipraseodymium dizirconium heptaoxide
Based on the results of the in vivo skin irritation studies in rabbits performed with the constituents of the substance, i.e. praseodymium(III,IV) oxide and zirconium dioxide, the substance of these two oxides is not expected to be capable of causing skin irritation in vivo either and is concluded not to be classified for this endpoint.
Eye irritation
1. Information on praseodymium(III,IV) oxide
In the guideline study performed by Shapiro (1991; Klimisch 2), 0.1 g of the test material was instilled into the left eye of six New Zealand white rabbits, with three of the treated eyes being rinsed after 30 seconds with saline. The animals were observed for 72 hours and the eyes examined at 24, 48 and 72 hours. Irritation was scored according to the method of Draize. In this study, the test item produced minimal irritation to both the unwashed and washed eyes but no classification is required under the conditions of this study in accordance with the CLP criteria.
2. Information on zirconium dioxide
In the guideline study performed by the Chemical Evaluation and Research Institute of Japan (2000; Klimisch 2), 0.1 g of yttrium zirconium oxide (test item with a low amount of yttrium oxide incorporated into the crystal lattice of zirconium dioxide) was instilled into the left eye of 3 New Zealand White rabbits. The results were calculated in terms of the Mean ocular irritation index (MOI). The test item was determined to be slightly irritating based on the AFNOR criteria, but the irritation was reversible at 72 h. It does not need to be classified for eye irritation according to the criteria of the CLP regulation. The results of this study were considered relevant for zirconium dioxide. The study was considered reliable with restrictions because no scores for each individual eye irritation endpoint for each individual animal were reported.
3. Conclusion on the substance dipraseodymium dizirconium heptaoxide
Based on the results of the in vivo eye irritation studies in rabbits performed with praseodymium(III,IV) oxide and yttrium zirconium oxide (i.e. zirconium dioxide with a small amount of yttrium oxide incorporated into its crystal lattice), the substance is not expected to be capable of causing eye irritation in vivo to an extent requiring classification for this endpoint either.
Justification for classification or non-classification
The substance dipraseodymium dizirconium heptaoxide does not need to be classified for skin or eye irritation based on the experimental results available for its constituents praseodymium(III,IV) oxide and zirconium dioxide (or zirconium dioxide with a small amount of yttrium oxide incorporated in its crystal lattice).
No data are available for respiratory irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.